Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2018Q2 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2018Q1 $ vs. 2018Q1
NEUROCRINE BIOSCIENCES INC 4,715,250 $463,226,000 12.14% -46,739 +$68,314,000
AMICUS THERAPEUTICS, INC. 20,024,424 $312,782,000 8.20% No Change +$11,615,000
Global Blood Therapeutics, Inc. 4,828,910 $218,266,000 5.72% -160,156 -$22,705,000
ALNYLAM PHARMACEUTICALS, INC. 1,846,911 $181,902,000 4.77% +566,109 +$29,359,000
ZOGENIX, INC. 3,970,357 $175,489,000 4.60% New +$175,489,000
Solid Biosciences Inc. 3,977,222 $141,708,000 3.71% +50,000 +$112,254,000
LA JOLLA PHARMACEUTICAL CO PAR $.0001 2 4,313,611 $125,828,000 3.30% No Change -$2,631,000
Biohaven Pharmaceutical Holding Co Ltd. 2,743,647 $108,429,000 2.84% -183,802 +$37,205,000
DOVA PHARMACEUTICALS INC 3,125,851 $93,525,000 2.45% +344,874 +$18,105,000
IOVANCE BIOTHERAPEUTICS, INC. 5,852,202 $74,908,000 1.96% -310,000 -$29,233,000
ACCELERON PHARMA INC 1,528,205 $74,149,000 1.94% +11,946 +$14,863,000
Ascendis Pharma A/S SPONSORED ADR 1,072,647 $71,352,000 1.87% +90,000 +$7,087,000
Verrica Pharmaceuticals Inc. 3,410,412 $67,287,000 1.76% New +$67,287,000
REGENXBIO Inc. 867,106 $62,215,000 1.63% -14,000 +$35,914,000
Blueprint Medicines Corp 961,147 $61,014,000 1.60% -69,287 -$33,477,000
Alector, Inc. 1,704,330 $60,504,000 1.59% No Change +$4,994,000
ALEXION PHARMACEUTICALS, INC. 463,450 $57,537,000 1.51% -410,000 -$39,818,000
Retrophin, Inc. 3,212,871 $57,387,000 1.50% No Change -$14,452,000
MERIT MEDICAL SYSTEMS INC 1,082,013 $55,399,000 1.45% +37,000 +$8,008,000
uniQure N.V. 1,444,628 $54,607,000 1.43% New +$54,607,000
MyoKardia, Inc. 1,089,169 $54,078,000 1.42% +254,490 +$13,346,000
MeiraGTx Holdings plc 4,703,398 $53,900,000 1.41% New +$53,900,000
Kadmon Holdings, Inc. 13,165,746 $52,531,000 1.38% +8,000,000 +$30,577,000
Quotient Ltd 6,483,020 $52,058,000 1.36% New +$52,058,000
CORIUM INTERNATIONAL INC 6,357,133 $50,921,000 1.33% No Change -$21,995,000